Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

3rd EurocanPlatform Translational Research Course /
From genotype to molecular phenotype by proteomics

12th - 16th Oct 2015

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 22.12.15
Views: 1863

Dr Janne Lehtiö - Karolinska Institutet, Stockholm, Sweden

Dr Lehtiö explains how the field of proteomics is beginning to reach the fore of cancer research, at the 3rd EurocanPlatform Translational Research Course.

He describes how proteomics can help in understanding how to combine current cancer treatments, what the next steps are in his research and the field in general as well as what the eventual benefit will be.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation